Menu

Nitrogen Dioxide Linked to Thousands of Premature Deaths in Germany

The findings of an official report come a month after a German court ruled in favor of banning diesel cars.

Mar 11, 2018
Diana Kwon

PIXABAY, DARIUSZSANKOWSKI

Nitrogen dioxide, a toxic particle released from diesel fumes, was linked to around 6,000 deaths in Germany in 2014, according to a report released by the country’s Federal Environmental Agency (Umweltbundesamt, or UBA) this Thursday (March 8).

“This study shows how much nitrogen dioxide harms health in Germany,” the head of the Federal Office for the Environment, Maria Krautzberger, tells the Associated Press (via Time). “We should do everything to make our air clean and healthy.”

According to Reuters, the report also notes that nitrogen dioxide levels are higher than air quality standards allow in 70 cities.

See “German Carmakers Funded Tests of Diesel Fumes on Monkeys and Humans

Last month (February 27), Germany’s Federal Administrative Court in Leipzig—the country’s highest administrative court—ruled that cities were allowed to ban diesel cars. The decision came after Environmental Action Germany, a nonprofit environmental organization, filed lawsuits against the authorities of the German cities Stuttgart and Dusseldorf, where pollution greatly exceeded the levels that the law permits, The Washington Post reported in February. Some politicians were critical of the decision, and Chancellor Angela Merkel noted that while concerns about individual cities should be addressed, it shouldn’t affect the whole of Germany, according to Deutsche Welle.

“This decision opens the door to clean air,” Tim Butler, who leads an air-quality research group at the Institute for Advanced Sustainability Studies in Potsdam, told the Post. “There’s going to be a huge problem in figuring out how to implement and enforce these bans. But ultimately, it’s the most effective way of cleaning the air, so it has to be done.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.